Page last updated: 2024-08-21

azomycin and clarithromycin

azomycin has been researched along with clarithromycin in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (28.57)	18.2507
2000's	15 (42.86)	29.6817
2010's	8 (22.86)	24.3611
2020's	2 (5.71)	2.80

Authors

Authors	Studies
Celle, G; Mela, GS; Savarino, V; Vigneri, S	1
Goddard, AF; Logan, RP	1
Hackelsberger, A; Malfertheiner, P	1
Johnston, BJ; Reed, PI	1
Misiewicz, JJ	1
Bell, JM; Grayson, ML; Lambert, JR; Midolo, PD; Turnidge, JD	1
Scheen, AJ	1
Axon, AT; Mapstone, N; Moayyedi, P; Ragunathan, PL; Tompkins, DS	2
Gisbert, JP	1
De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL	1
Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M	1
Calvet, X; Gabriel, R; García, N; Gisbert, JP; González, L; López, T; Pajares, JM; Roqué, M	1
De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL	1
Kuipers, EJ; Kusters, JG	1
Beales, IL	1
Ho, B; Ling, KL; Luman, W; Ng, HS	1
Börsch, G; Kahl, S; Labenz, J; Leodolter, A; Malfertheiner, P; Peitz, U; Stolte, M; Sulliga, M; Von Arnim, U; Wolle, K	1
Malfertheiner, P; Pilotto, A	1
Nilsson, LE; Nilsson, M; Sörberg, M; Ström, M; Svensson, M	1
Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T	1
Calvet, X; Gisbert, JP; Gonzalez, L	1
Chadha, R; Jain, DV; Kumar, A	1
Moayyedi, P	1
Essa, AS; Graham, DY; Kramer, JR; Treiber, G	1
Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S; Vilaichone, RK	1
Calvet, X; Gisbert, JP	1
Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y	1
Kang, BK; Kim, BW; Park, SM	1
Almeida, N; Calhau, C; Cardoso, O; Cipriano, MA; Donato, MM; Fernandes, A; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C	1
Guo, B; Li, BZ; Li, P; Mao, C; Threapleton, DE; Wang, JY; Xu, JM; Ye, DQ; Ye, QL; Yuan, JQ; Zhang, C	1
Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gasbarrini, A; Gisbert, JP; Graham, DY; Hunt, R; Kuipers, EJ; Malfertheiner, P; Megraud, F; Moayyedi, P; O'Morain, CA; Rokkas, T; Rugge, M; Selgrad, M; Suerbaum, S; Sugano, K	1
Jo, KW; Nam, GB; Shim, TS; Yoon, HY	1
Birkenfeld, S; Boltin, D; Dotan, I; Gabay, H; Gingold-Belfer, R; Levi, Z; Schmilovitz-Weiss, H; Shochat, T	1
Chen, J; Ding, Z; Huang, Y; Liang, X; Lu, H	1

Reviews

16 review(s) available for azomycin and clarithromycin

Article	Year
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. Drug safety, 1996, Volume: 15, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines	1996
Treatment of Helicobacter pylori infection. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1997, Volume: 51, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors	1997
Management of Helicobacter pylori-related disorders. European journal of gastroenterology & hepatology, 1997, Volume: 9 Suppl 1 Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pumps	1997
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. Revista espanola de enfermedades digestivas, 1999, Volume: 91, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Nitroimidazoles; Omeprazole; Penicillins	1999
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	2000
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine	2000
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors	2000
Antibiotic resistance of Helicobacter pylori. Symposium series (Society for Applied Microbiology), 2001, Issue:30 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline	2001
Review article: an approach to Helicobacter pylori infection in the elderly. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:4 Topics: Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Peptic Ulcer; Treatment Failure	2002
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter, 2005, Volume: 10, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine	2005
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter, 2009, Volume: 14, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Alimentary pharmacology & therapeutics, 2011, Volume: 34, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic	2011
Optimum duration of regimens for Helicobacter pylori eradication. The Cochrane database of systematic reviews, 2013, Dec-11, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones	2013
[New therapeutic strategies against Helicobacter pylori]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Mar-25, Volume: 63, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors	2014
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ (Clinical research ed.), 2015, Aug-19, Volume: 351 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Nitroimidazoles; Probiotics; Proton Pump Inhibitors	2015
Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis. Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome	2022

Trials

4 trial(s) available for azomycin and clarithromycin

Article	Year
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors	2000
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore. Singapore medical journal, 2001, Volume: 42, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Omeprazole; Singapore; Tinidazole	2001
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Treatment Outcome	2002
Sequential regimens for Helicobacter pylori eradication. Lancet (London, England), 2007, Sep-22, Volume: 370, Issue:9592 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome	2007

Other Studies

16 other study(ies) available for azomycin and clarithromycin

Article	Year
Helicobacter pylori eradication and reinfection. Lancet (London, England), 1995, Jun-24, Volume: 345, Issue:8965 Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Omeprazole; Peptic Ulcer; Ranitidine	1995
Antimicrobial resistance and Helicobacter pylori. The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:4 Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles	1996
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology, 1997, Volume: 29, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; Nitroimidazoles; Tetracycline	1997
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Revue medicale de Liege, 1998, Volume: 53, Issue:1 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer	1998
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Journal of gastroenterology, 1998, Volume: 33, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Tinidazole; Treatment Failure	1998
Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Journal of gastroenterology, 1998, Volume: 33 Suppl 10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitroimidazoles; Omeprazole; Tinidazole; Treatment Failure	1998
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome	2001
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC gastroenterology, 2001, Volume: 1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Ranitidine; Treatment Outcome	2001
Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7 Topics: Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Microbial Sensitivity Tests; Nitroimidazoles	2002
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. International journal of antimicrobial agents, 2004, Volume: 24, Issue:5 Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure	2004
Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique. Die Pharmazie, 2007, Volume: 62, Issue:5 Topics: Algorithms; Anti-Ulcer Agents; Buffers; Calorimetry; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Drug Incompatibility; Hydrogen Bonding; Hydrogen-Ion Concentration; Macrolides; Nitroimidazoles; Omeprazole; Roxithromycin; Solvents; Thermodynamics	2007
Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Chi-Square Distribution; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Odds Ratio; Point Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Proton Pump Inhibitors; Ribotyping; Risk Assessment; Risk Factors; RNA, Ribosomal, 23S; Thailand; Time Factors; Treatment Outcome	2011
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country? BMC gastroenterology, 2015, Feb-15, Volume: 15 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Nitroimidazoles; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Young Adult	2015
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut, 2017, Volume: 66, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Early Detection of Cancer; Evidence-Based Medicine; Fluoroquinolones; Gastritis; Gastrointestinal Microbiome; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach; Stomach Neoplasms	2017
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 09-01, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Effect of Previous Nitroimidazole Treatment on Helicobacter pylori Eradication Success. Journal of clinical gastroenterology, 2020, Volume: 54, Issue:4 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome	2020